John W. Childs - Mar 4, 2025 Form 4 Insider Report for Biohaven Ltd. (BHVN)

Role: Director
Signature: /s/ George Clark, Attorney-in-Fact
Stock symbol: BHVN
Transactions as of: Mar 4, 2025
Transactions value $: $996,238
Form type: 4
Date filed: 3/5/2025, 07:01 AM
Previous filing: Dec 31, 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BHVN	Common Shares	Purchase	$760K	+25K	+1.09%	$30.39	2.32M	Mar 4, 2025	By John W Childs 2013 Revocable Trust	F1
transaction	BHVN	Common Shares	Purchase	$104K	+3.4K	+16.15%	$30.73	24.5K	Mar 4, 2025	By 2007 Charitable Remainder Trust	F2
transaction	BHVN	Common Shares	Purchase	$104K	+3.4K	+4.65%	$30.73	76.6K	Mar 4, 2025	By 2013 Charitable Remainder Trust	F2
transaction	BHVN	Common Shares	Purchase	$27.7K	+900	+3.69%	$30.73	25.3K	Mar 4, 2025	By 1994 Charitable Remainder Trust	F2
holding	BHVN	Common Shares						4.1M	Mar 4, 2025	By 2021 B-H Charitable Remainder Trust

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $30.17 - $30.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
F2	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $30.54 - $30.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $30.17 - $30.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $30.54 - $30.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.